Hologic has completed the acquisition of Endomagnetics, a privately held U.K.-based developer of breast cancer surgery technologies, for approximately $310 million.
The transaction adds Endomagnetics’ wireless breast surgery localization and lymphatic tracing tools to Hologic's breast surgery portfolio, including the Magseed marker, the Magtrace lymphatic tracer, and the Sentimag platform. These new offerings will give breast surgeons and radiologists more options, according to Hologic.
